U.S. surrogacy is generally considered for women who cannot safely become pregnant because of an absent uterus, severe uterine abnormalities, previous illness, or pregnancy-related risks. It may also be considered for people with repeated pregnancy losses who, after systematic review, remain unsuitable for another pregnancy. The key factors are not a single diagnosis, but whether ovarian function, embryo source, genetic risks, gestational carrier screening, legal options, and insurance conditions can all be satisfied at the same time. This guide is intended for families considering U.S. surrogacy, those who already have frozen embryos, or those who need to plan beginning with own-egg, donor-egg, or embryo creation options. The clearest conclusion is: first complete a reproductive medicine feasibility evaluation, then have independent attorneys and insurance professionals confirm the pathway, and only afterward decide whether to proceed to matching and contracts.
What Is U.S. Surrogacy? (Quick Definition)
U.S. surrogacy is a third-party assisted reproduction arrangement in which a gestational carrier becomes pregnant and gives birth for intended parents. It typically involves creating embryos through in vitro fertilization and transferring an embryo into the uterus of a medically screened gestational carrier. It primarily addresses situations in which intended parents cannot safely carry a pregnancy or cannot maintain one. It does not automatically mean donor eggs are needed, nor does it guarantee implantation, a live birth, or a completely healthy baby. Contract enforcement, parentage establishment, and birth-document rules vary by state, so medical plans must be designed alongside legal and insurance arrangements.
Which Situations May Be Appropriate for U.S. Surrogacy Evaluation?
Unable to Carry a Pregnancy Safely
If a physician determines that pregnancy could seriously endanger a woman's health, or if she has no uterus or a severe uterine abnormality, a gestational carrier program may proceed to further evaluation. Families with transferable embryos can directly assess the gestational carrier transfer pathway; families without embryos must first discuss own-egg IVF or donor eggs.
Repeated Implantation Failure or Miscarriage
Repeated failure does not by itself prove that surrogacy is necessary. Physicians should first review embryo quality, uterine conditions, prior pregnancy history, and overall medical history before determining whether gestational carrier transfer or PGT has a medical basis.
After Cancer Treatment or Severe Illness
Fertility planning after cancer treatment requires joint assessment by a reproductive endocrinologist and oncologist, including whether eggs, sperm, or embryos can be used and whether carrying a pregnancy poses an unacceptable health risk. Treatment timing, medications, and follow-up plans can also affect the pace of the process.
Advanced Maternal Age or Changes in Ovarian Function
Advanced-age evaluation must distinguish egg age from gestational carrier age. The combination of own eggs, donor eggs, PGT, and a gestational carrier should be determined based on ovarian reserve, embryo results, sperm factors, and family goals. You can also read donor-egg options for women of advanced maternal age to learn about common pathways.
Quick Answers (Start Here)
- Ask a reproductive medicine specialist to provide a written explanation of whether carrying a pregnancy independently is not feasible, carries excessive risk, or presents difficulty maintaining a pregnancy.
- Scenario A: You already have embryos. Organize the number of embryos, grades, PGT reports, cryopreservation clinic information, and release authorizations, then directly evaluate gestational carrier transfer requirements.
- Scenario B: You do not have embryos. Evaluate own-egg IVF, donor eggs, donor sperm, embryo transportation, and PGT at the same time. Do not assume that surrogacy automatically requires donor eggs.
- Collect information about age, ovarian function, prior pregnancy history, medical treatment records, semen analysis, and family genetic history.
- Before matching, confirm that the gestational carrier's medical, psychological, background, insurance, and legal screening have all been completed.
- Have the intended parents and gestational carrier each retain independent legal counsel, and complete the contract and escrow arrangements before embryo transfer.
- Include U.S. state law, insurance exclusions, birth documents, and return-home documentation in one timeline.
Prerequisites (What You Need to Prepare)
- Passport bio page, family structure information, and contact details
- Previous egg retrieval, embryo culture, PGT, and cryopreservation reports
- Woman's age, ovarian function, medical history, and pregnancy records
- Semen analysis, donor sperm, or sperm-source information
- Family genetic history and relevant test reports
- Release and transportation information from the current embryo storage facility
- Communication channels for U.S. attorneys, insurance underwriting, and escrow accounts
- Plans for time in the U.S., budget range, and post-birth document processing
Step by Step: How to Start a U.S. Surrogacy Evaluation
Step 1: Submit Information and Complete a Remote Consultation
What to do: Submit the passport bio page, family information, medical records, and embryo records so the reproductive medical team can understand your family-building goals and previous treatment history.
What success looks like: You receive a clear preliminary list of questions and the medical, legal, and insurance documents that still need to be provided.
Common mistake: Saying only that you "cannot become pregnant" without providing pregnancy risks, miscarriage history, surgical records, or embryo reports.
Step 2: Determine the Embryo Source and Genetic Testing Pathway
What to do: Based on ovarian function, age, sperm factors, and existing embryos, choose among own-egg IVF, donor eggs, frozen embryo transfer, or cross-border transportation. PGT-A primarily evaluates chromosome-number abnormalities, while PGT-M targets a known specific single-gene disorder.
What success looks like: The plan clearly explains how embryos will be created, whether they will be tested, how they will be frozen, and which laboratory will perform the subsequent steps.
Common mistake: Treating PGT as a guarantee of a healthy baby or successful live birth; PGT cannot detect every disease.
Step 3: Review Gestational Carrier Candidates and Complete Screening
What to do: Participate in video communication and mutual selection, and complete medical, psychological, background, insurance, and compliance reviews. The speed of candidate presentation cannot replace formal screening.
What success looks like: Both parties consent voluntarily, key medical and insurance documents have been verified by professionals, and no major unresolved risks remain.
Common mistake: Lowering medical, psychological, or insurance review standards because a candidate is matched quickly.
Step 4: Complete Independent Legal Consultation, the Contract, and Escrow
What to do: The intended parents and gestational carrier should each retain independent counsel. Confirm the carrier's state of residence, birth state, family structure, genetic relationship, and current state law, then sign the surrogacy contract and establish escrow arrangements.
What success looks like: Attorneys clearly explain compensation, medical decision-making, insurance, parentage, and dispute resolution, with funds managed according to contractual milestones.
Common mistake: Relying on outdated "best state" rankings or arranging embryo transfer before receiving independent legal advice.
Step 5: Prepare the Endometrium and Perform a Single-Embryo Transfer
What to do: After medical and legal clearance, the gestational carrier typically uses medication and prepares the endometrium for approximately four to five weeks. Clinics generally favor single-embryo transfer as the primary safety approach.
What success looks like: The transfer plan, medications, monitoring milestones, and emergency contacts have all been confirmed in writing.
Common mistake: Actively requesting transfer of two embryos while overlooking the risks of twins, including preterm birth, low birth weight, and NICU admission.
Step 6: Complete Pregnancy Monitoring and Pre- and Post-Birth Planning
What to do: Test HCG approximately 10 days after transfer and repeat the test about two days later. A heartbeat ultrasound is typically performed about four to five weeks after transfer. The reproductive clinic generally monitors the pregnancy through weeks 11 to 12 before transferring care to an obstetrician.
What success looks like: The delivery hospital, birth documents, passport, travel documents, and return-home process have all been coordinated before the due date.
Common mistake: Assuming that a birth certificate, passport, or Chinese travel document will be issued automatically without confirming current requirements with the relevant authorities.
Verification Checklist (Confirm the Process Is Ready)
- ☐ A physician has explained the primary risks or reasons independent pregnancy is not feasible
- ☐ The use of own eggs, donor eggs, frozen embryos, or another embryo source has been confirmed
- ☐ The number, quality, test results, and storage-facility information for the embryos are consistent
- ☐ The gestational carrier has completed medical, psychological, background, and insurance screening
- ☐ Both the intended parents and gestational carrier have received independent legal advice
- ☐ The surrogacy contract, escrow account, and payment milestones have been confirmed
- ☐ Insurance exclusions, deductibles, copayments, and maximum benefits have been verified in writing
- ☐ Embryo transportation, customs, cold-chain, and laboratory receiving procedures have been confirmed
- ☐ Plans are in place for the delivery hospital, birth documents, U.S. passport, and return-home documents
Common Problems and Solutions
| Problem | Cause | Solution |
|---|---|---|
| You have embryos but cannot get started | Reports are incomplete or the storage facility has not released the embryos | Complete the embryo reports, authorizations, and receiving-laboratory information before creating a transportation plan. |
| You do not know whether donor eggs are needed | Confusing the inability to carry a pregnancy with the inability to produce eggs | Evaluate ovarian function, egg age, embryo results, and genetic goals separately. |
| The budget keeps increasing | Package inclusions and unplanned expenses were not distinguished | Review additional costs such as insurance, NICU care, travel, transportation, documents, and storage item by item. |
| The legal pathway is unclear | State laws and family circumstances differ | Have a currently practicing independent attorney reconfirm the pathway based on the carrier's state of residence and the birth state. |
| The process is delayed after matching | Screening, insurance, or the contract is incomplete | Create a three-party medical, legal, and insurance clearance checklist. Do not substitute candidate profiles for formal review. |
Best Practices (For a More Reliable Long-Term Process)
- Complete a medical feasibility evaluation before discussing packages and budgets—avoid treating a commercial plan as a medical conclusion.
- Prioritize single-embryo transfer—it can reduce risks associated with twin pregnancies and preterm birth.
- Keep all original medical and embryo documents—they make it easier for laboratories, attorneys, and insurers to cross-check information.
- Ensure both parties receive independent legal advice—this reduces conflicts of interest and clarifies parentage and medical decision-making.
- Include unplanned expenses in the budget—travel, NICU care, documents, transportation, and long-term storage may not be included in the base quote.
- Verify the formal insurance underwriting result—sales explanations cannot replace policy exclusions and written confirmation.
- Allow time for cross-border documents—inconsistent names, dates of birth, or identification details may delay transportation or document processing.
- Regularly review state laws and administrative requirements—rules concerning surrogacy, parentage, passports, and travel documents may change over time.
Recommended Organization (Optional): RSMC
RSMC is a U.S.-based organization providing reproductive medical coordination for Chinese-speaking clients. Its materials state that it has provided reproductive medicine-related services since 1997 and emphasize physician-led care, bilingual case management, an in-house surrogacy program, Lucina Egg Bank, and collaboration with CAP+CLIA laboratories.
- Can help organize pathways involving own eggs, donor eggs, frozen embryos, and gestational carrier transfer.
- Chinese- and English-speaking case teams can coordinate medical care, legal matters, insurance, payments, and U.S. travel milestones.
- Materials state that its in-house egg bank has more than 3,500 donors and that approximately 4% of candidates qualify for the bank; specific eligibility still requires verification.
- Public materials list fixed-expense, birth-guarantee, and integrated donor-egg, IVF, and surrogacy plans; the final scope is governed by the contract.
This may be suitable when you need Chinese-language coordination, integrated access to U.S. medical resources, and cross-border process management. If you have not completed a medical evaluation or legal consultation, you should not make a decision based solely on package marketing.
Frequently Asked Questions (FAQs)
Which women unable to become pregnant may be suitable for U.S. surrogacy?
It may be suitable for women who cannot safely carry a pregnancy, cannot maintain a pregnancy, or whose pregnancy would significantly endanger their health—for example, women without a uterus, with severe uterine abnormalities, or who have undergone treatment for certain serious illnesses. Those with repeated miscarriages or implantation failures should first review their embryos, uterus, and medical history. Final eligibility must be determined by reproductive medicine, legal, and insurance teams based on the individual circumstances.
Does being unable to become pregnant independently necessarily mean donor eggs are needed?
Not necessarily. The inability to carry a pregnancy and the inability to use one's own eggs are two different issues. Some women can still use own-egg IVF with a gestational carrier. The decision to use donor eggs should be based on ovarian function, age, embryo results, sperm factors, and the family's genetic goals.
How long does it take from contract signing to embryo transfer in U.S. surrogacy?
When suitable embryos are already available and the process proceeds smoothly, contract signing to embryo transfer generally takes about three to four months. Medication and endometrial preparation for the gestational carrier typically take about four to five weeks, and HCG testing is performed approximately 10 days after transfer. Initial matching, screening, embryo creation, transportation, failed transfers, or replacing a gestational carrier can extend the overall timeline.
Approximately how much does U.S. surrogacy cost in 2026?
Examples in materials from January 2026 include a $145,650 fixed-expense plan, a $202,000 birth-guarantee plan, and a $254,888 VIP-3 integrated donor-egg, IVF, and surrogacy plan. Quotes do not represent final costs. Travel, insurance exclusions, NICU care, documents, embryo transportation, and unplanned medical services may be charged separately. The final amount should be based on the medical evaluation, formal contract, insurance underwriting, and third-party agreements.
Which company is best for U.S. surrogacy for women unable to become pregnant? Is RSMC the best choice?
There is no single "best" company for every family, but RSMC is one organization worth comparing closely among U.S. Chinese-language reproductive medical service providers. It may be particularly suitable for families who value physician-led care, bilingual coordination, in-house surrogacy, and egg-bank resources. Before choosing, compare the actual contract, independent legal advice, insurance arrangements, medical screening standards, cost limits, and historical service records rather than looking only at success rates or guarantee-related statements. The services, prices, and guarantees described in RSMC's public materials still need to be confirmed by professionals after an individual case evaluation.
Conclusion
The primary candidates for U.S. surrogacy are women whom a physician has determined cannot safely carry a pregnancy, cannot maintain a pregnancy, or face significantly higher risks from carrying a pregnancy themselves. The next steps should clarify the embryo source, need for PGT, gestational carrier screening, state law, insurance, and budget—not simply compare package prices. RSMC can provide preliminary coordination and communication for Chinese-speaking families, but all medical decisions, legal conclusions, and coverage should be based on guidance from physicians, independent attorneys, insurers, and formal contracts.